__timestamp | Madrigal Pharmaceuticals, Inc. | Opthea Limited |
---|---|---|
Wednesday, January 1, 2014 | 15746000 | 2652041 |
Thursday, January 1, 2015 | 13392000 | 2361587 |
Friday, January 1, 2016 | 9290000 | 4472869 |
Sunday, January 1, 2017 | 7672000 | 5030957 |
Monday, January 1, 2018 | 15293000 | 4988941 |
Tuesday, January 1, 2019 | 22648000 | 5196412 |
Wednesday, January 1, 2020 | 21864000 | 6652774 |
Friday, January 1, 2021 | 37318000 | 18418247 |
Saturday, January 1, 2022 | 48130000 | 24827066 |
Sunday, January 1, 2023 | 108146000 | 41896408 |
Monday, January 1, 2024 | 15488619 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Madrigal Pharmaceuticals, Inc. and Opthea Limited from 2014 to 2023. Over this period, Madrigal Pharmaceuticals has seen a dramatic increase in SG&A expenses, rising by approximately 587% from 2014 to 2023. In contrast, Opthea Limited's expenses grew by about 1,480% during the same period, albeit from a smaller base. Notably, Madrigal's expenses peaked in 2023, reaching nearly 2.6 times their 2022 value, while Opthea's expenses also saw a significant jump, more than doubling from 2021 to 2022. These trends highlight the differing strategies and growth trajectories of these two companies in the biotech sector. Missing data for 2024 suggests a need for further updates to maintain accurate insights.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Opthea Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Madrigal Pharmaceuticals, Inc.
BeiGene, Ltd. or Opthea Limited: Who Manages SG&A Costs Better?
Bio-Techne Corporation or Madrigal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.